[HTML][HTML] Effect of vitamin D supplementation on cardiac-metabolic risk factors in elderly: a systematic review and meta-analysis of clinical trials

M Qorbani, M Zarei, Y Moradi, G Appannah… - Diabetology & metabolic …, 2022 - Springer
Background There has been a longstanding interest in the potential effect of vitamin D in
preventing cardiac-metabolic diseases. However, there are divergent results regarding the …

Pharmacological modulation of vascular ageing: A review from VascAgeNet

L Roth, S Dogan, BG Tuna, T Aranyi, S Benitez… - Ageing research …, 2023 - Elsevier
Vascular ageing, characterized by structural and functional changes in blood vessels of
which arterial stiffness and endothelial dysfunction are key components, is associated with …

[HTML][HTML] Reduced nitric oxide synthesis in winter: A potential contributing factor to increased cardiovascular risk

L Liddle, C Monaghan, MC Burleigh, KA Baczynska… - Nitric Oxide, 2022 - Elsevier
Background Nitric oxide is a key signalling molecule that elicits a range of biological
functions to maintain vascular homeostasis. A reduced availability of nitric oxide is …

[HTML][HTML] Vitamin D level regulates serum lipids discrepantly in adults with and without dyslipidemia

YL Cheng, TI Lee, YM Chien, TW Lee… - Endocrine …, 2023 - ec.bioscientifica.com
Vitamin D deficiency is associated with hyperlipidemia, but it remains unclear whether
vitamin D supplementation reduces serum lipid levels. The aims of this study were to …

[HTML][HTML] Micronutrient depletion in heart failure: common, clinically relevant and treatable

N Cvetinovic, G Loncar, AM Isakovic… - International journal of …, 2019 - mdpi.com
Heart failure (HF) is a chronic condition with many imbalances, including nutritional issues.
Next to sarcopenia and cachexia which are clinically evident, micronutrient deficiency is also …

[HTML][HTML] Vitamin D supplementation is effective for olanzapine-induced dyslipidemia

Z Zhou, T Nagashima, C Toda, M Kobayashi… - Frontiers in …, 2023 - frontiersin.org
Olanzapine is an atypical antipsychotic drug that is clinically applied in patients with
schizophrenia. It increases the risk of dyslipidemia, a disturbance of lipid metabolic …

[HTML][HTML] Impact of vitamin D receptor gene polymorphisms (TaqI and BsmI) on the incidence and severity of coronary artery disease: a report from southern Iran

B Akhlaghi, N Firouzabadi, F Foroughinia… - BMC cardiovascular …, 2023 - Springer
Background The association of vitamin D level and vitamin D receptor (VDR) gene
polymorphisms with the prevalence of coronary artery disease (CAD) has been evaluated in …

[HTML][HTML] Vitamin D and lipid profiles in postmenopausal women: a Meta-analysis and Systematic review of randomized controlled trials

W Liu, Z Wu, D Zhu, G Chen, G Yan, S Zhang… - Frontiers in Molecular …, 2021 - frontiersin.org
Background and Aim: It is known that hyperlipidemia and low vitamin D level are risk factors
associated with cardiovascular disease (CVD). However, the effect of vitamin D …

Association of serum 25-Hydroxy Vitamin D level with lipid, lipoprotein, and apolipoprotein level

C Elmi, MM Fan, M Le, G Cheng… - Journal of Community …, 2021 - Taylor & Francis
ABSTRACT Introduction 25-Hydroxy vitamin D (Vit D3) deficiency was found to be
associated with vascular dysfunction, arterial stiffening, extent of coronary artery disease …

JCS 2023 guideline on the primary prevention of coronary artery disease

A Fujiyoshi, S Kohsaka, J Hata, M Hara, H Kai… - Circulation …, 2024 - jstage.jst.go.jp
Pathological studies of the coronary arteries in children and young adults have shown that
atherosclerosis can be observed from childhood. In autopsy cases of children, the greater …